Effects of Different Remote Ischemia Perconditioning Methods on Cerebral Infarct Volume and Neurological Impairment in Rats
Authors
Affiliations
Remote ischemic perconditioning (RIPerC) is a novel neuroprotective method against cerebral infarction that has shown efficacy in animal studies but has not been consistently neuroprotective in clinical trials. We focused on the temporal regulation of ischemia-reperfusion by RIPerC to establish an optimal method for RIPerC. Rats were assigned to four groups: 10 min ischemia, 5 min reperfusion; 10 min ischemia, 10 min reperfusion; 5 min ischemia, 10 min reperfusion; and no RIPerC. RIPerC interventions were performed during ischemic stroke, which was induced by a 60-min left middle cerebral artery occlusion. Infarct volume, sensorimotor function, neurological deficits, and cellular expressions of brain-derived neurotrophic factor (BDNF), B-cell lymphoma 2 (Bcl-2), Bcl-2-associated X protein (Bax), and caspase 3 were evaluated 48 h after the induction of ischemia. Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling (TUNEL) was also performed. RIPerC of 10 min ischemia/10 min reperfusion, and 5 min ischemia/10 min reperfusion decreased infarct volume, improved sensorimotor function, decreased Bax, caspase 3, and TUNEL-positive cells, and increased BDNF and Bcl-2 expressions. Our findings suggest RIPerC with a reperfusion time of approximately 10 min exerts its neuroprotective effects via an anti-apoptotic mechanism. This study provides important preliminary data to establish more effective RIPerC interventions.
Li Y, Wu J, Du F, Tang T, Lim J, Karuppiah T Pharmaceuticals (Basel). 2024; 17(11).
PMID: 39598404 PMC: 11597102. DOI: 10.3390/ph17111493.
Wu X, Meier L, Liu T, Toldo S, Poelzing S, Gourdie R Diagnostics (Basel). 2024; 14(20).
PMID: 39451648 PMC: 11507200. DOI: 10.3390/diagnostics14202325.
Wu X, Meier L, Liu T, Toldo S, Poelzing S, Gourdie R bioRxiv. 2024; .
PMID: 39229206 PMC: 11370443. DOI: 10.1101/2024.08.16.608294.
Kongsui R, Jittiwat J Biomed Rep. 2024; 20(6):85.
PMID: 38665422 PMC: 11040226. DOI: 10.3892/br.2024.1773.
Zhao J, Zhu R, He F, Wu M, Wu Y, Meng X Exp Ther Med. 2024; 27(4):154.
PMID: 38476925 PMC: 10928996. DOI: 10.3892/etm.2024.12442.